These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9532231)

  • 1. [Dementia-related diseases. Propentofyllin--a neuroprotective glia cell modulator].
    Nervenarzt; 1998 Feb; 69(2 Suppl Propentofy):1-4. PubMed ID: 9532231
    [No Abstract]   [Full Text] [Related]  

  • 2. Glial modulating and neurotrophic properties of propentofylline and its application to Alzheimer's disease and vascular dementia.
    Ringheim GE
    Ann N Y Acad Sci; 2000 Apr; 903():529-34. PubMed ID: 10818548
    [No Abstract]   [Full Text] [Related]  

  • 3. Investigating the natural course and treatment of vascular dementia and Alzheimer's disease. Parallel study populations in two randomized, placebo-controlled trials.
    Kittner B; De Deyn PP; Erkinjuntti T
    Ann N Y Acad Sci; 2000 Apr; 903():535-41. PubMed ID: 10818549
    [No Abstract]   [Full Text] [Related]  

  • 4. Anticoagulant therapy for dementia.
    Walsh AC
    J Clin Psychiatry; 1990 Dec; 51(12):522. PubMed ID: 2082987
    [No Abstract]   [Full Text] [Related]  

  • 5. Propentofylline in the treatment of Alzheimer's disease and vascular dementia: a review of phase III trials.
    Rother M; Erkinjuntti T; Roessner M; Kittner B; Marcusson J; Karlsson I
    Dement Geriatr Cogn Disord; 1998 Jul; 9 Suppl 1():36-43. PubMed ID: 9716243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HWA 285 (propentofylline)--a new compound for the treatment of both vascular dementia and dementia of the Alzheimer type.
    Rother M; Kittner B; Rudolphi K; Rössner M; Labs KH
    Ann N Y Acad Sci; 1996 Jan; 777():404-9. PubMed ID: 8624121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.
    Masterman D
    Clin Geriatr Med; 2004 Feb; 20(1):59-68. PubMed ID: 15062487
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical trials of propentofylline in vascular dementia. European/Canadian Propentofylline Study Group.
    Kittner B
    Alzheimer Dis Assoc Disord; 1999; 13 Suppl 3():S166-71. PubMed ID: 10609697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memantine in the treatment of dementia.
    Maggiore C; Locatelli L; Grandi FC; Pizzolato G;
    Neuroepidemiology; 2007; 28(2):118-9. PubMed ID: 17409774
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug treatment of cerebral disorders in senility].
    Schelling JL
    Ther Umsch; 1982 Nov; 39(11):887-90. PubMed ID: 7179174
    [No Abstract]   [Full Text] [Related]  

  • 11. [Good and not good studies. New therapeutic studies on antidementia agents].
    Müller WE
    Pharm Unserer Zeit; 2002; 31(4):382-8. PubMed ID: 12162068
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevention and treatment of senile dementia].
    Otomo E
    Nihon Ronen Igakkai Zasshi; 1990 May; 27(3):310-3. PubMed ID: 2214307
    [No Abstract]   [Full Text] [Related]  

  • 13. Economic impact of introducing propentofylline for the treatment of dementia in Sweden.
    Wimo A; Witthaus E; Rother M; Winblad B
    Clin Ther; 1998; 20(3):552-66; discussion 550-1. PubMed ID: 9663370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances.
    Expert Consensus Panel for Dementia
    Postgrad Med; 2005 Jan; Spec No():1-111. PubMed ID: 17203560
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical trials in dementia with propentofylline.
    Kittner B; Rössner M; Rother M
    Ann N Y Acad Sci; 1997 Sep; 826():307-16. PubMed ID: 9329701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of rispolept in mental disorders in patients with Alzheimer and vascular types of dementia].
    Shamreĭ VK; Kolchev AI; Dobrovol'skaia NV
    Voen Med Zh; 2002 Nov; 323(11):47-51. PubMed ID: 12532483
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antihypertensive drugs for dementia?].
    Schrader J
    MMW Fortschr Med; 2003 Aug; 145(33-34):47-8. PubMed ID: 14526575
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug therapy of dementia. Improving cognitive performance].
    MMW Fortschr Med; 2001 May; 143(18):53. PubMed ID: 11387714
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential therapeutic targets of huperzine A for Alzheimer's disease and vascular dementia.
    Zhang HY; Zheng CY; Yan H; Wang ZF; Tang LL; Gao X; Tang XC
    Chem Biol Interact; 2008 Sep; 175(1-3):396-402. PubMed ID: 18565502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Differentiating between Alzheimer disease and vascular dementia? Currently no longer significant].
    Wettstein A
    Fortschr Med Orig; 2001 Nov; 119(3-4):139-40. PubMed ID: 11789126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.